Turning Point Benefit Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-96
Closed -$103K 487
2025
Q4
$103K Buy
96
+28
+41% +$26.8K 0.05% 122
2025
Q3
$56.1K Buy
+68
New +$50.6K 0.03% 138

Other funds holding LLY

Turning Point Benefit Group's LLY Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 96 shares — an estimated $103K sold.

Turning Point Benefit Group first reported a position in LLY in Q3 2025 and held it in 2 quarters. The position peaked at $103K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 96 Eli Lilly shares in Q1 2026, an estimated $103K.
  • Turning Point Benefit Group first reported a position in Eli Lilly in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Eli Lilly position peaked at $103K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.